Cell BiologybioRxivPreprint
Focal adhesion pathway inhibition is the central axis of macrophage phenotypic responses to monoclonal antibody therapy in aggressive lymphoma via high-throughput screening and high-content imaging
Stuart James Blakemore, Peter Zentis, Linda Müller…·Christian Philipp Pallasch
This study identifies focal adhesion pathway inhibition as a key mechanism enhancing macrophage phagocytosis and improving anti-CD20 monoclonal antibody therapy in aggressive lymphoma through high-throughput screening and high-content imaging.
DOI 10.1101/2025.09.23.677924